BSE Live
Jan 19, 11:19Prev. Close
6233.95
Open Price
6233.95
Bid Price (Qty.)
6148.05 (5)
Offer Price (Qty.)
6153.70 (20)
NSE Live
Jan 19, 11:19Prev. Close
6236.00
Open Price
6236.00
Bid Price (Qty.)
6151.50 (8)
Offer Price (Qty.)
6153.00 (9)
| Key Financial Ratios of Divis Laboratories (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 25.75 | 64.33 | 53.84 | 143.95 | 54.24 | |
| Diluted EPS (Rs.) | 25.75 | 64.33 | 53.84 | 143.95 | 54.24 | |
| Cash EPS (Rs.) | 29.80 | 72.25 | 60.54 | 177.65 | 65.90 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 114.86 | 191.70 | 133.43 | 414.68 | 265.14 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 114.86 | 191.70 | 133.43 | 414.68 | 265.14 | |
| Revenue from Operations/Share (Rs.) | 71.43 | 182.70 | 160.33 | 567.74 | 301.05 | |
| PBDIT/Share (Rs.) | 33.15 | 77.22 | 65.27 | 193.98 | 97.39 | |
| PBIT/Share (Rs.) | 29.26 | 69.84 | 59.75 | 176.68 | 85.81 | |
| PBT/Share (Rs.) | 29.17 | 69.22 | 58.48 | 169.80 | 82.42 | |
| Net Profit/Share (Rs.) | 25.75 | 64.33 | 53.84 | 143.95 | 54.24 | |
| NP After MI And SOA / Share (Rs.) | 25.75 | 64.33 | 53.84 | 143.95 | 54.24 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 46.41 | 42.26 | 40.71 | 34.16 | 32.34 | |
| PBIT Margin (%) | 40.95 | 38.22 | 37.26 | 31.11 | 28.50 | |
| PBT Margin (%) | 40.83 | 37.88 | 36.47 | 29.90 | 27.37 | |
| Net Profit Margin (%) | 36.05 | 35.21 | 33.58 | 25.35 | 18.01 | |
| NP After MI And SOA Margin (%) | 36.05 | 35.21 | 33.58 | 25.35 | 18.01 | |
| Return on Networth/Equity (%) | 22.42 | 33.55 | 40.35 | 34.71 | 20.45 | |
| Return on Capital Employed (%) | 21.27 | 31.05 | 35.79 | 28.26 | 16.22 | |
| Return on Assets (%) | 18.23 | 26.79 | 29.38 | 21.96 | 10.71 | |
| Total Debt/Equity (X) | 0.02 | 0.04 | 0.10 | 0.29 | 0.44 | |
| Asset Turnover Ratio (%) | 50.58 | 76.09 | 87.49 | 86.63 | 59.45 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 3.02 | 3.60 | 2.66 | 2.25 | 1.60 | |
| Quick Ratio (X) | 1.15 | 1.62 | 1.33 | 1.12 | 0.77 | |
| Inventory Turnover Ratio (X) | 1.89 | 2.81 | 3.68 | 3.43 | 2.10 | |
| Dividend Payout Ratio (NP) (%) | 23.29 | 9.33 | 7.42 | 6.94 | 18.43 | |
| Dividend Payout Ratio (CP) (%) | 20.13 | 8.31 | 6.60 | 5.62 | 15.17 | |
| Earnings Retention Ratio (%) | 76.71 | 90.67 | 92.58 | 93.06 | 81.57 | |
| Cash Earnings Retention Ratio (%) | 79.87 | 91.69 | 93.40 | 94.38 | 84.83 | |
| Coverage Ratios | ||||||
| Interest Coverage Ratios (%) | 324.89 | 112.78 | 47.01 | 25.69 | 25.35 | |
| Interest Coverage Ratios (Post Tax) (%) | 324.89 | 112.78 | 47.01 | 25.69 | 25.35 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 8,989.63 | 6,213.18 | 8,264.16 | 4,110.45 | 2,538.94 | |
| EV/Net Operating Revenue (X) | 9.52 | 5.25 | 7.98 | 5.61 | 6.58 | |
| EV/EBITDA (X) | 20.52 | 12.42 | 19.61 | 16.41 | 20.34 | |
| MarketCap/Net Operating Revenue (X) | 9.51 | 5.22 | 7.92 | 5.42 | 6.22 | |
| Retention Ratios (%) | 76.70 | 90.66 | 92.57 | 93.05 | 81.56 | |
| Price/BV (X) | 5.91 | 4.97 | 9.51 | 7.42 | 7.06 | |
| Price/Net Operating Revenue | 9.51 | 5.22 | 7.92 | 5.42 | 6.22 | |
| Earnings Yield | 0.04 | 0.07 | 0.04 | 0.05 | 0.03 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill